NIPH
TEVA icon

NN Investment Partners Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

NN Investment Partners Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-173,451
Closed -$1.6M – 777
2019
Q2 		$1.6M Sell
173,451
-59,678
-26% -$720K 0.01% 513
2019
Q1 		$3.65M Sell
233,129
-277,464
-54% -$4.89M 0.03% 387
2018
Q4 		$7.87M Buy
+510,593
New +$10.5M 0.07% 224
2017
Q4 		– Sell
-5,924
Closed -$197K – 675
2017
Q3 		$197K Hold
5,924
– – ﹤0.01% 669
2017
Q2 		$197K Sell
5,924
-275,000
-98% -$8.51M ﹤0.01% 725
2017
Q1 		$9.02M Sell
280,924
-2,241,276
-89% -$76.5M 0.09% 192
2016
Q4 		$91.4M Buy
2,522,200
+1,449,368
+135% +$57.9M 0.86% 25
2016
Q3 		$49.4M Buy
+1,072,832
New +$56M 0.46% 63

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

NN Investment Partners Holdings's TEVA Position: Q3 2019 in Review

NN Investment Partners Holdings sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 173,451 shares — an estimated $1.6M sold.

NN Investment Partners Holdings first reported a position in TEVA in Q3 2016 and held it in 8 quarters. The position peaked at $91.4M in Q4 2016. 428 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • NN Investment Partners Holdings reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • NN Investment Partners Holdings sold 173,451 Teva Pharmaceuticals shares in Q3 2019, an estimated $1.6M.
  • NN Investment Partners Holdings first reported a position in Teva Pharmaceuticals in Q3 2016 and held it in 8 quarters.
  • NN Investment Partners Holdings's Teva Pharmaceuticals position peaked at $91.4M in Q4 2016.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on NN Investment Partners Holdings's 13F filing for Q3 2019, filed 12 Nov 2019.